JBIO Jade Biosciences, Inc.

Fundamentals / CIK 0001798749 / USD

Jade Biosciences, Inc. reported $486.4M in total assets and a net loss of $163.1M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open JBIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$0$0$0-$119.1MFY 2020 Net Income: -$9.61M2020FY 2021 Net Income: -$22.96M2021FY 2022 Net Income: -$51.51M2022FY 2023 Net Income: -$75.52M2023FY 2024 Net Income: -$69.63M2024FY 2025 Net Income: -$127.4M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $93.12M $53.19M $64.22M $38.62M $14.99M $7.94M
Total Operating Expenses $113.5M $74.60M $81.41M $53.24M $23.02M $8.89M
Operating Income -$113.5M -$74.60M -$81.41M -$53.24M -$23.02M -$8.89M
EBITDA -$113.5M -$74.31M -$81.31M -$53.17M -$23.01M -$8.89M
Interest Expense -- -- -- -- -- $75K
Income Before Tax -$127.4M -$69.57M -$75.47M -$51.49M -$22.96M -$9.61M
Income Tax Expense $58K $55K $56K $25K $3.0K --
Net Income -$127.4M -$69.63M -$75.52M -$51.51M -$22.96M -$9.61M
Basic EPS -$3.19 -$22.32 -$26.26 -$19.21 -$17.11 -$368.80
Diluted EPS -$3.19 -$22.32 -$26.26 -$19.21 -$17.11 -$368.80
Basic Shares Outstanding 31.4M 3.1M 2.9M 2.7M 1.3M 26.5K
Diluted Shares Outstanding 31.4M 3.1M 2.9M 2.7M 1.3M 26.5K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $30.82M $50.06M $36.05M $28.54M $22.01M $22.55M $20.02M $1.53M
Total Operating Expenses $39.64M $58.92M $43.45M $34.98M $27.40M $27.78M $23.38M $6.40M
Operating Income -$39.64M -$58.92M -$43.45M -$34.98M -$27.40M -$27.78M -$23.38M -$6.40M
EBITDA -$39.62M -$58.91M -$43.44M -$34.97M -$27.39M -$27.78M -$23.38M -$6.39M
Income Before Tax -$35.05M -$55.75M -$40.35M -$31.87M -$25.18M -$32.13M -$38.17M --
Income Tax Expense $10K $15K $16K -- $0 $0 -- $0
Net Income -$35.05M -$55.77M -$40.37M -$31.93M -$25.18M -$32.13M -$38.17M -$5.43M
Basic EPS -$0.42 -$0.76 -$0.57 -- -$0.48 -$0.86 -$12.10 --
Diluted EPS -$0.42 -$0.76 -$0.57 -- -$0.48 -$0.86 -$12.10 --
Basic Shares Outstanding 71.8M 61.1M 57.8M -- 39.6M 28.4M 3.2M --
Diluted Shares Outstanding 71.8M 61.1M 57.8M -- 39.6M 28.4M 3.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $88.44M $69.39M $23.49M $22.40M $54.20M $4.57M
Short-Term Investments $247.7M $0 $98.95M $106.8M $113.2M --
Cash & Short-Term Investments $336.2M $78.60M $122.4M $129.2M $167.4M $4.57M
Total Current Assets $348.8M $69.65M $124.2M $131.5M $174.3M $4.68M
Property, Plant & Equipment, Net $170K $0 $288K $242K $186K $39K
Other Non-Current Assets $69K $3.15M $2.28M $2.56M $302K --
Total Non-Current Assets $965K $3.15M $3.19M $3.81M $1.03M $39K
Total Assets $349.8M $72.80M $127.4M $135.3M $175.4M $4.71M
Accounts Payable $2.15M $1.29M $2.40M $2.58M $1.21M $618K
Other Current Liabilities -- -- -- -- -- $18K
Total Current Liabilities $16.54M $12.00M $17.64M $7.78M $2.55M $1.77M
Total Non-Current Liabilities $724K $107.6M $325K $776K $395K $0
Total Liabilities $17.26M $119.6M $17.96M $8.56M $2.94M $1.77M
Total Debt (incl. Leases) $851K $417K $675K $1.09M $574K --
Common Stock $5.0K $1.0K $3.0K $2.0K $2.0K --
Retained Earnings -$174.4M -$46.98M -$163.4M -$87.90M -$36.39M -$13.41M
Accumulated Other Comp. Income $129K $0 $237K -$466K -$59K --
Total Stockholders' Equity $332.5M -$46.80M $109.5M $126.7M $172.4M -$13.34M
Total Equity $332.5M -$46.80M $109.5M $126.7M $172.4M -$13.34M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $80.39M $107.2M $55.09M $88.44M $50.11M $220.9M $44.22M $69.39M
Short-Term Investments $395.3M $354.0M $256.2M $247.7M $148.8M -- $31.99M $0
Cash & Short-Term Investments $475.7M $461.2M $311.3M $336.2M $198.9M $220.9M $76.20M $78.60M
Total Current Assets $485.6M $471.3M $318.5M $348.8M $201.4M $223.0M $77.37M $69.65M
Property, Plant & Equipment, Net $136K $144K $157K $170K $176K $147K $2.0K $0
Other Non-Current Assets $69K $69K $69K $69K $174K $60K -- $3.15M
Total Non-Current Assets $830K $862K $916K $965K $1.09M $984K $160K $3.15M
Total Assets $486.4M $472.1M $319.4M $349.8M $202.4M $224.0M $77.53M $72.80M
Accounts Payable $3.02M $6.58M $3.98M $2.15M $1.35M $7.59M $69K $1.29M
Total Current Liabilities $30.29M $31.57M $22.29M $16.54M $22.36M $21.62M $2.42M $12.00M
Total Non-Current Liabilities $594K $628K $679K $724K $747K $792K $70K $107.6M
Total Liabilities $30.89M $32.20M $22.97M $17.26M $23.10M $22.41M $2.49M $119.6M
Total Debt (incl. Leases) $733K $761K $808K $851K $867K $811K $312K $417K
Common Stock $7.0K $6.0K $5.0K $5.0K $3.0K $3.0K $3.0K $1.0K
Retained Earnings -$305.6M -$270.5M -$214.8M -$174.4M -$142.5M -$117.3M -$235.6M -$46.98M
Accumulated Other Comp. Income -$2.07M -$660K -$342K $129K $29K -$24K $50K $0
Total Stockholders' Equity $455.5M $439.9M $296.5M $332.5M $179.3M $201.6M -$83.51M -$46.80M
Total Equity $455.5M $439.9M $296.5M $332.5M $179.3M $201.6M -$83.51M -$46.80M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$127.4M -$69.63M -$75.52M -$51.51M -$22.96M -$9.61M
Depreciation & Amortization $26K $282K $96K $68K $15K $1.0K
Stock-Based Compensation $20.01M $11.31M $11.91M $5.48M $2.04M $58K
Change in Payables $361K -$2.17M -$164K $1.37M $609K $37K
Operating Cash Flow -$94.69M -$71.20M -$56.78M -$39.12M -$27.40M -$7.86M
Capital Expenditure -$196K -- -$142K -$195K -$181K --
Free Cash Flow -$94.89M -- -$56.92M -$39.32M -$27.58M --
Purchases of Investments -$261.2M -- -- -- -$113.3M --
Sales & Maturities of Investments $14.41M -- -- -- -- --
Investing Cash Flow -$247.0M $56.03M $11.88M $6.93M -$113.4M --
Common Stock Issued -- $23.94M $44.89M -- $126.9M --
Financing Cash Flow $360.8M $25.43M $46.00M $396K $190.5M $8.92M
Net Change in Cash $19.05M $10.26M $1.09M -$31.80M $49.62M $1.06M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$35.05M -$55.77M -$40.37M -$31.93M -$25.18M -$32.13M -$38.17M -$5.43M
Depreciation & Amortization $16K $9.0K $9.0K $9.0K $12K $1.0K $4.0K $8.0K
Stock-Based Compensation $7.07M $13.61M $7.41M $9.40M $4.29M $3.90M $2.42M $1.24M
Change in Payables -$3.05M $2.10M $2.33M $301K -$4.88M $2.26M $2.68M -$684K
Operating Cash Flow -$28.91M -$43.66M -$24.08M -$33.65M -$22.12M -$20.16M -$18.76M -$11.05M
Purchases of Investments -$74.93M -$142.3M -$73.90M -- -- -- -- --
Sales & Maturities of Investments $32.63M $44.69M $65.43M -- -- -- -- --
Investing Cash Flow -$42.30M -$97.63M -$8.47M -$98.16M -$148.7M -$12.99M $12.85M $13.13M
Financing Cash Flow $44.35M $193.5M -$795K $170.2M $0 $191.3M -$700K $554K
Net Change in Cash -$26.86M $52.16M -$33.35M $38.33M -$170.8M $171.0M -$19.46M $2.64M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -38.3% -- -69.0% -40.6% -13.3% --
Return on Assets (ROA) -36.4% -95.6% -59.3% -38.1% -13.1% -203.8%
Current Ratio 21.09x 5.81x 7.04x 16.90x 68.37x 2.64x
Quick Ratio 20.33x 6.55x 6.94x 16.60x 65.65x 2.58x
Debt to Equity 0.00x -- 0.01x 0.01x 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -35.8% -34.8% -43.7% -38.3% -56.3% -45.9% -- --
Return on Assets (ROA) -33.5% -32.5% -40.6% -36.4% -49.8% -41.3% -109.9% -96.5%
Current Ratio 16.03x 14.93x 14.29x 21.09x 9.01x 10.31x 32.01x 5.81x
Quick Ratio 15.70x 14.61x 13.96x 20.33x 8.90x 10.22x 31.53x 6.55x
Debt to Equity 0.00x 0.00x 0.00x 0.00x 0.00x 0.00x -- --
Source: SEC EDGAR CompanyFacts (CIK 0001798749) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:30 UTC · Open in terminal